Responses
Other responses
Jump to comment:
- Published on: 26 August 2016
- Published on: 14 July 2016
- Published on: 26 August 2016Re:It is important to distinguish between HFrEF and HFpEF when interpreting these dataShow More
We would like to thank Dr Cunnington for his interest in our study and raising some potentially interesting points . We do not have a breakdown of patients with heart failure ( HF) who had either preserved (HFpEF) or reduced ejection fraction (HFrEF) . Since beta-blockers only have a licensed indication for HFrEF on the basis of an echocardiogram , we do not believe that this is likely to be a relevant factor withi...
Conflict of Interest:
None declared. - Published on: 14 July 2016It is important to distinguish between HFrEF and HFpEF when interpreting these dataShow More
In this interesting article, Lipworth and colleagues report that beta -blockers are underused in patients with heart failure (HF) and COPD, compared to those with HF alone. However, they do not quote the proportion of "HF" patients within their dataset who had HF with reduced ejection fraction (HFrEF; left ventricular ejection fraction (LVEF) <40%) and HF with preserved ejection fraction (HFpEF; LVEF >50%). This d...
Conflict of Interest:
None declared.